Paul Wachter, Director at Avalanche Biotechnologies, Inc. ([AAVL]), sold 1,192 shares at $35.31 ($42K) on 2015-05-18, disclosed to the SEC on 2015-05-19.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| [AAVL] | SELL | 2015-06-10 | $46K | — | Filing → |
| [AAVL] | SELL | 2015-06-02 | $43K | — | Filing → |
| [AAVL] | SELL | 2015-05-27 | $44K | — | Filing → |